LISA BEACHY: Open Payments
NPI 1073184628 · OLDSMAR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,219 in 215 payments from 22 companies in 2025. Trend: 2023 $5,030 · 2024 $5,004 · 2025 $4,219
Food & beverage: $4,219
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 42 | $710 |
| ABBVIE INC. | 19 | $391 |
| GENZYME CORPORATION | 7 | $385 |
| PFIZER INC. | 19 | $325 |
| ANI Pharmaceuticals, Inc. | 32 | $321 |
| UCB, Inc. | 24 | $294 |
| AstraZeneca Pharmaceuticals LP | 7 | $280 |
| GlaxoSmithKline, LLC. | 12 | $265 |
| Lilly USA, LLC | 7 | $173 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $167 |
Products named: XELJANZ, PURIFIED CORTROPHIN GEL, KEVZARA, Bimzelx, SAPHNELO, RINVOQ, BENLYSTA, EVENITY.
Industry payments across FL — which companies pay providers there.
